IMDX (STOCKS)
Insight Molecular Diagnostics Inc. Common Stock
$3.000000
-0.170000 (-5.36%)
Prev close: $3.170000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Joshua Riggs
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $97.15M
- Employees
- 49
- P/E (TTM)
- -1.85
- P/B (TTM)
- -2.73
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.72 | $-0.24 | -0.4780 | -197.52% |
|
Sep 2025 (Q3)
|
$-0.34 | $-0.21 | -0.1261 | -58.95% |
|
Jun 2025 (Q2)
|
$-0.30 | $-0.23 | -0.0654 | -27.88% |
|
Mar 2025 (Q1)
|
$-0.26 | $-0.24 | -0.0188 | -7.79% |
Financial Statements
| Revenues | $4.06M |
| Benefits Costs and Expenses | $54.28M |
| Cost Of Revenue | $1.75M |
| Costs And Expenses | $54.28M |
| Gross Profit | $2.30M |
| Nonoperating Income/Loss | $902.00K |
| Operating Expenses | $53.42M |
| Depreciation and Amortization | $2.19M |
| Research and Development | $15.90M |
| Other Operating Expenses | $35.33M |
| Operating Income/Loss | -$51.12M |
| Income/Loss From Continuing Operations After Tax | -$50.22M |
| Income/Loss From Continuing Operations Before Tax | -$50.22M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Income/Expense After Provision For Losses | -$109.00K |
| Interest Income/Expense Operating, Net | -$109.00K |
| Net Income/Loss | -$50.22M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$50.22M |
| Net Income/Loss Available To Common Stockholders, Basic | -$50.22M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$1.65 |
| Diluted Earnings Per Share | -$1.65 |
| Basic Average Shares | 30,476,000 |
| Diluted Average Shares | 30,476,000 |
| Assets | $25.76M |
| Current Assets | $15.31M |
| Inventory | $446.00K |
| Other Current Assets | $14.86M |
| Noncurrent Assets | $10.45M |
| Fixed Assets | $9.25M |
| Intangible Assets | $0.00 |
| Other Non-current Assets | $1.20M |
| Liabilities | $57.22M |
| Current Liabilities | $12.08M |
| Accounts Payable | $2.54M |
| Other Current Liabilities | $9.53M |
| Noncurrent Liabilities | $45.15M |
| Equity | -$31.46M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$31.46M |
| Liabilities And Equity | $25.76M |
| Net Cash Flow From Operating Activities | -$22.18M |
| Net Cash Flow From Operating Activities, Continuing | -$22.18M |
| Net Cash Flow From Investing Activities | -$3.19M |
| Net Cash Flow From Investing Activities, Continuing | -$3.19M |
| Net Cash Flow From Financing Activities | $28.07M |
| Net Cash Flow From Financing Activities, Continuing | $28.07M |
| Net Cash Flow | $2.70M |
| Net Cash Flow, Continuing | $2.70M |
| Comprehensive Income/Loss | -$50.16M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$50.16M |
| Other Comprehensive Income/Loss | -$50.16M |